Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 21, 2011. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific executive transaction rather than a financial performance report.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details a specific share transaction by an executive:
- Executive: Mr. J M Clarke
- Action: Exercise of share options and immediate sale of shares.
- Details: Exercised options over 90,000 Ordinary shares granted on December 3, 2002, at an exercise price of £11.79 per share.
- Disposition: Sold 90,000 Ordinary shares on December 21, 2011, at a price of £14.41 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total number of shares held by Mr. J M Clarke following this transaction.
- Confirm the impact of this transaction on the company's total outstanding share count (if applicable).
- Review the full GlaxoSmithKline Share Option Plan terms regarding the 2002 grant.